SEARCH RESULTS for assignee:"alnylam pharmaceuticals"

Showing 1 to 20 of 56 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15212884: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

(A1) 20170067060: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

(B2) 9: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

Reel/Frame

Last Update:

Patent(s)

(X0) 15603069: NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

(A1) 20180043009: NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

(B2) 1: NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Reel/Frame

Last Update:

Patent(s)

(X0) 15027176: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

(A1) 20160244766: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

(B2) 1: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

Reel/Frame

Last Update:

Patent(s)

(X0) 15027176: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

(A1) 20160244766: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

(B2) 1: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

Reel/Frame

Last Update:

Patent(s)

(X0) 15110658: RNAi AGENTS MODIFIED AT THE 4'-C POSITION

(A1) 20170029815: RNAi AGENTS MODIFIED AT THE 4'-C POSITION

(B2) 1: RNAi AGENTS MODIFIED AT THE 4'-C POSITION

Reel/Frame

Last Update:

Patent(s)

(X0) 14889352: DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

(A1) 20160122759: DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

Reel/Frame

Last Update:

Patent(s)

(X0) 16007517: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES

(A1) 20180282728: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES

Reel/Frame

Last Update:

Patent(s)

(X0) 15847631: Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene

(A1) 20180282725: Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene

Reel/Frame

Last Update:

Patent(s)

(X0) 14420189: CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION

(A1) 20150196655: CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION

(B2) 1: CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION

Reel/Frame

Last Update:

Patent(s)

(X0) 16002034: STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

(A1) 20180273955: STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15661132: ORGANIC COMPOSITIONS TO TREAT BETA-ENAC-RELATED DISEASES

(A1) 20170327829: ORGANIC COMPOSITIONS TO TREAT BETA-ENAC-RELATED DISEASES

(B2) 1: ORGANIC COMPOSITIONS TO TREAT BETA-ENAC-RELATED DISEASES

Reel/Frame

Last Update:

Patent(s)

(X0) 14650128: PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

(A1) 20160017335: PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15026897: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

(A1) 20160264966: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

(B2) 1: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

Reel/Frame

Last Update:

Patent(s)

(X0) 15026897: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

(A1) 20160264966: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

(B2) 1: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

Reel/Frame

Last Update:

Patent(s)

(X0) 15843656: SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT

(A1) 20180120749: SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT

Reel/Frame

Last Update:

Patent(s)

(X0) 14700938: METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA

(A1) 20160024498: METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA

(B2) 1: METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA

Reel/Frame

Last Update:

Patent(s)

(X0) 15745591: MULTI-TARGETED SINGLE ENTITY CONJUGATES

(A1) 20180208927: MULTI-TARGETED SINGLE ENTITY CONJUGATES

Reel/Frame

Last Update:

Patent(s)

(X0) 15917990: POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF

(A1) 20180201936: POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15743349: INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

(A1) 20180201929: INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 14814911: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

(A1) 20160115476: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE